Percutaneous thermal ablation for the treatment of colorectal liver metastases and hepatocellular carcinoma: a comparison of local therapeutic efficacy

References

• Nishikawa H, Kimura T, Kita R, et al. (2013). Radiofrequency ablation for hepatocellular carcinoma. Int J Hyperthermia 29:558–68.
   PubMed Web of Science ®Google Scholar
• Chen MH, Yang W, Yan K, et al. (2004). Large liver tumors: protocol for radiofrequency ablation and its clinical application in 110 patients-mathematic model, overlapping mode, and electrode placement process. Radiology 232:260–71.
   PubMed Web of Science ®Google Scholar
• Fong Y, Kemeny N, Paty P, et al. (1996). Treatment of colorectal cancer: hepatic metastasis. Semin Surg Oncol 12:219–52.
   PubMed Web of Science ®Google Scholar
• Shady W, Petre EN, Gonen M, et al. (2016). Percutaneous radiofrequency ablation of colorectal cancer liver metastases: factors affecting outcomes–a 10-year experience at a single center. Radiology 278:601–11.
   PubMed Web of Science ®Google Scholar
• Solbiati L, Ahmed M, Cova L, et al. (2012). Small liver colorectal metastases treated with percutaneous radiofrequency ablation: local response rate and long-term survival with up to 10-year follow-up. Radiology 265:958–68.
   PubMed Web of Science ®Google Scholar
• Sorensen SM, Mortensen FV, Nielsen DT. (2007). Radiofrequency ablation of colorectal liver metastases: long-term survival. Acta Radiol 48:253–8.
   PubMed Web of Science ®Google Scholar
• Pathak S, Jones R, Tang JM, et al. (2011). Ablative therapies for colorectal liver metastases: a systematic review. Colorectal Dis 13:e252–65.
   Google Scholar
• Alberts SR. (2012). Update on the optimal management of patients with colorectal liver metastases. Crit Rev Oncol Hematol 84:59–70.
   PubMed Web of Science ®Google Scholar
• Bruix J, Sherman M. (2011). Management of hepatocellular carcinoma: an update. Hepatology 53:1020–2.
   PubMed Web of Science ®Google Scholar
• N'Kontchou G, Mahamoudi A, Aout M, et al. (2009). Radiofrequency ablation of hepatocellular carcinoma: long-term results and prognostic factors in 235 Western patients with cirrhosis. Hepatology 50:1475–83.
   PubMed Web of Science ®Google Scholar
• Lee DH, Lee JM, Lee JY, et al. (2014). Radiofrequency ablation of hepatocellular carcinoma as first-line treatment: long-term results and prognostic factors in 162 patients with cirrhosis. Radiology 270:900–9.
   PubMed Web of Science ®Google Scholar
• Naugler WE, Sonnenberg A. (2010). Survival and cost-effectiveness analysis of competing strategies in the management of small hepatocellular carcinoma. Liver Transpl 16:1186–94.
   PubMed Web of Science ®Google Scholar
• Kim KH, Yoon YS, Yu CS, et al. (2011). Comparative analysis of radiofrequency ablation and surgical resection for colorectal liver metastases. J Korean Surg SOC 81:25–34.
   PubMedGoogle Scholar
• Lu MD, Yin XY, Xie XY, et al. (2005). Percutaneous thermal ablation for recurrent hepatocellular carcinoma after hepatectomy. Br J Surg 92:1393–8.
   PubMed Web of Science ®Google Scholar
• Tateishi R, Shiina S, Teratani T, et al. (2005). Percutaneous radiofrequency ablation for hepatocellular carcinoma. An analysis of 1000 cases. Cancer 103:1201–9.
   PubMed Web of Science ®Google Scholar
• Flanders VL, Gervais DA. (2010). Ablation of liver metastases: current status. J Vasc Interv Radiol 21:S214–22.
   PubMed Web of Science ®Google Scholar
• Solbiati L, Livraghi T, Goldberg SN, et al. (2001). Percutaneous radio-frequency ablation of hepatic metastases from colorectal cancer: long-term results in 117 patients. Radiology 221:159–66.
   PubMed Web of Science ®Google Scholar
• He N, Jin QN, Wang D, et al. (2016). Radiofrequency ablation vs. hepatic resection for resectable colorectal liver metastases. J Huazhong Univ Sci Technol Med Sci 36:514–18.
   PubMed Web of Science ®Google Scholar
• Weng M, Zhang Y, Zhou D, et al. (2012). Radiofrequency ablation versus resection for colorectal cancer liver metastases: a meta-analysis. PLoS One 7:e45493.
   PubMed Web of Science ®Google Scholar
• Lee KH, Kim HO, Yoo CH, et al. (2012). Comparison of radiofrequency ablation and resection for hepatic metastasis from colorectal cancer. Korean J Gastroenterol 59:218–23.
   PubMedGoogle Scholar
• Khajanchee YS, Hammill CW, Cassera MA, et al. (2011). Hepatic resection vs minimally invasive radiofrequency ablation for the treatment of colorectal liver metastases: a Markov analysis. Arch Surg 146:1416–23.
   PubMedGoogle Scholar
• Wu YZ, Li B, Wang T, et al. (2011). Radiofrequency ablation vs hepatic resection for solitary colorectal liver metastasis: a meta-analysis. World J Gastroenterol 17:4143–8.
   PubMed Web of Science ®Google Scholar
• Hof J, Wertenbroek MW, Peeters PM, et al. (2016). Outcomes after resection and/or radiofrequency ablation for recurrence after treatment of colorectal liver metastases. Br J Surg 103:1055–62.
   PubMed Web of Science ®Google Scholar
• Facciorusso A, Di Maso M, Muscatiello N. (2016). Microwave ablation versus radiofrequency ablation for the treatment of hepatocellular carcinoma: a systematic review and meta-analysis. Int J Hyperthermia 32:339–44.
   PubMed Web of Science ®Google Scholar
• Li M, Yu X, Liang P, et al. (2015). Ultrasound-guided percutaneous microwave ablation for hepatic malignancy adjacent to the gallbladder. Int J Hyperthermia 31:579–87.
   PubMed Web of Science ®Google Scholar
• Li M, Yu XL, Liang P, et al. (2012). Percutaneous microwave ablation for liver cancer adjacent to the diaphragm. Int J Hyperthermia 28:218–26.
   PubMed Web of Science ®Google Scholar
• Ahmed M, Solbiati L, Brace CL, et al. (2014). Image-guided tumor ablation: standardization of terminology and reporting criteria—a 10-year update. J Vasc Interv Radiol 25:1691–705.
   PubMed Web of Science ®Google Scholar
• Mulier S, Ni Y, Jamart J, Ruers T, et al. (2005). Local recurrence after hepatic radiofrequency coagulation: multivariate meta-analysis and review of contributing factors. Ann Surg 242:158–71.
   PubMed Web of Science ®Google Scholar
• Wang X, Sofocleous CT, Erinjeri JP, et al. (2013). Margin size is an independent predictor of local tumor progression after ablation of colon cancer liver metastases. Cardiovasc Intervent Radiol 36:166–75.
   PubMed Web of Science ®Google Scholar
• Thomasset SC, Dennison AR, Garcea G. (2015). Ablation for recurrent hepatocellular carcinoma: a systematic review of clinical efficacy and prognostic factors. World J Surg 39:1150–60.
   PubMed Web of Science ®Google Scholar
• Sofocleous CT, Petre EN, Gonen M, et al. (2011). CT-guided radiofrequency ablation as a salvage treatment of colorectal cancer hepatic metastases developing after hepatectomy. J Vasc Interv Radiol 22:755–61.
   PubMed Web of Science ®Google Scholar
• Veltri A, Sacchetto P, Tosetti I, et al. (2008). Radiofrequency ablation of colorectal liver metastases: small size favorably predicts technique effectiveness and survival. Cardiovasc Intervent Radiol 31:948–56.
   PubMed Web of Science ®Google Scholar
• Gillams AR, Lees WR. (2009). Five-year survival in 309 patients with colorectal liver metastases treated with radiofrequency ablation. Eur Radiol 19:1206–13.
   PubMed Web of Science ®Google Scholar
• Sofocleous CT, Nascimento RG, Petrovic LM, et al. (2008). Histopathologic and immunohistochemical features of tissue adherent to multitined electrodes after RF ablation of liver malignancies can help predict local tumor progression: initial results. Radiology 249:364–74.
   PubMed Web of Science ®Google Scholar
• Bale R, Widmann G, Schullian P, et al. (2012). Percutaneous stereotactic radiofrequency ablation of colorectal liver metastases. Eur Radiol 22:930–37.
   PubMed Web of Science ®Google Scholar
• Pawlik TM, Izzo F, Cohen DS, et al. (2003). Combined resection and radiofrequency ablation for advanced hepatic malignancies: results in 172 patients. Ann Surg Oncol 10:1059–69.
   PubMed Web of Science ®Google Scholar
• Vogl TJ, Straub R, Eichler K, et al. (2004). Colorectal carcinoma metastases in liver: laser-induced interstitial thermotherapy-local tumor control rate and survival data. Radiology 230:450–8.
   PubMed Web of Science ®Google Scholar
• Kim YS, Rhim H, Cho OK, et al. (2006). Intrahepatic recurrence after percutaneous radiofrequency ablation of hepatocellular carcinoma: analysis of the pattern and risk factors. Eur J Radiol 59:432–41.
   PubMed Web of Science ®Google Scholar
• Nakazawa T, Kokubu S, Shibuya A, et al. (2007). Radiofrequency ablation of hepatocellular carcinoma: correlation between local tumor progression after ablation and ablative margin. AJR Am J Roentgenol 188:480–8.
   PubMed Web of Science ®Google Scholar
• Kim YS, Lee WJ, Rhim H, et al. (2010). The minimal ablative margin of radiofrequency ablation of hepatocellular carcinoma (>2 and <5 cm) needed to prevent local tumor progression: 3D quantitative assessment using CT image fusion. AJR Am J Roentgenol 195:758–65.
   PubMed Web of Science ®Google Scholar
• Sofocleous CT, Klein KM, Hubbi B, et al. (2004). Histopathologic evaluation of tissue extracted on the radiofrequency probe after ablation of liver tumors: preliminary findings. AJR Am J Roentgenol 183:209–13.
   PubMed Web of Science ®Google Scholar
• Hoffman AL, Wu SS, Obaid AK, et al. (2002). Histologic evaluation and treatment outcome after sequential radiofrequency ablation and hepatic resection for primary and metastatic tumors. Am Surg 68:1038–43.
   PubMed Web of Science ®Google Scholar
• Liu CH, Arellano RS, Uppot RN, et al. (2010). Radiofrequency ablation of hepatic tumours: effect of post-ablation margin on local tumour progression. Eur Radiol 20:877–85.
   PubMed Web of Science ®Google Scholar
• Ayav A, Germain A, Marchal F, et al. (2010). Radiofrequency ablation of unresectable liver tumors: factors associated with incomplete ablation or local recurrence. Am J Surg 200:435–9.
   PubMed Web of Science ®Google Scholar
• Peng ZW, Zhang YJ, Chen MS, et al. (2008). Risk factors of survival after percutaneous radiofrequency ablation of hepatocellular carcinoma. Surg Oncol 17:23–31.
   PubMed Web of Science ®Google Scholar